{"nct_id":"NCT01880424","title":"A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2013-07","start_date_type":null,"primary_completion_date":"2015-05","primary_completion_date_type":"ACTUAL","completion_date":"2015-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}